Evidence map›Paper›PMID 42181408›Full record

ArticleCureus2026

From Inflammation to Malignancy: Diagnosing Ocular Adnexal Diffuse Large B-Cell Lymphoma Beyond Dacryocystitis.

Muhammad Yusuf Abdurrahman, Khairul-Anwar Ibrahim, Raja Nor Farahiyah Raja Othman, Akmal Haliza Zamli, Khairidzan Mohd Kamal

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Muhammad Yusuf AbdurrahmanOphthalmology, International Islamic University Malaysia, Kuala Lumpur, MYS.
Khairul-Anwar IbrahimOphthalmology, International Islamic University Malaysia Medical Specialist Center (IMSC), Kuantan, MYS.
Raja Nor Farahiyah Raja OthmanOphthalmology, Hospital Serdang, Serdang, MYS.
Akmal Haliza ZamliOphthalmology, Hospital Tengku Ampuan Afzan, Kuantan, MYS.
Khairidzan Mohd KamalOphthalmology, Kulliyyah of Medicine, International Islamic University Malaysia, Kuantan, MYS.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This case report discusses a 16-year-old male patient with a history of recurrent allergic rhinitis and sinusitis, who initially presented with left eyelid swelling, proptosis, and progressive facial edema extending from the left medial canthus to the nasal bridge. He was treated for nearly a year under the working diagnosis of chronic left dacryocystitis with multiple courses of topical, oral, and intravenous antibiotics. However, the patient developed worsening proptosis, progressive left-sided vision loss, and left submandibular lymphadenopathy, which ultimately guided the diagnostic focus toward ocular adnexal lymphoma (OAL) involving the left orbit. Despite multiple imaging studies and histopathological assessments, it took nearly a year to identify the exact pathology. This case report details the diagnostic journey, treatment strategies, and interventions employed to preserve the patient's vision, ultimately enabling him to resume normal activities. We emphasize that in cases of chronic, unresponsive dacryocystitis, ocular adnexal lymphoma should be considered in the differential diagnosis. Early surgical intervention plays a critical role in optimizing visual outcomes and should be pursued to avoid further morbidity associated with delayed diagnosis.

Indexed as

allergic rhinitischronic dacryocystitisextranodal marginal zone lymphomafacial swellingfine needle aspiration cytologynasolacrimal duct obstructionocular adnexal lymphomaperiocular swellingproptosissubmandibular lymphadenopathy

Identifiers

PMID42181408
PMCPMC13191338

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.